PDB Short entry for 1VZJ HEADER HYDROLASE 20-MAY-04 1VZJ TITLE STRUCTURE OF THE TETRAMERIZATION DOMAIN OF ACETYLCHOLINESTERASE: FOUR- TITLE 2 FOLD INTERACTION OF A WWW MOTIF WITH A LEFT-HANDED POLYPROLINE HELIX COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACETYLCHOLINESTERASE; COMPND 3 CHAIN: A, B, C, D, E, F, G, H; COMPND 4 FRAGMENT: C TERMINAL TETRAMERIZATION DOMAIN, RESIDUES 575-614; COMPND 5 SYNONYM: ACETYLCHOLINESTERASE COLLAGENIC TAIL PEPTIDE (WAT); COMPND 6 EC: 3.1.1.7; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: WAT CHAINS A-D INTERACT WITH PRAD CHAIN I WHILE WAT COMPND 9 CHAINS E-H INTERACT WITH PRAD CHAIN J; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: ACETYLCHOLINESTERASE COLLAGENIC TAIL PEPTIDE; COMPND 12 CHAIN: I, J; COMPND 13 FRAGMENT: PRAD PEPTIDE, RESIDUES 53-67; COMPND 14 SYNONYM: COLQ, ACETYLCHOLINESTERASE-ASSOCIATED COLLAGEN, ACHE Q COMPND 15 SUBUNIT; COMPND 16 ENGINEERED: YES; COMPND 17 OTHER_DETAILS: PROLINE RICH ATTACHMENT DOMAIN (PRAD) OF THE ACHE- COMPND 18 ASSOCIATED COLLAGEN PROTEIN (COLQ) SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 OTHER_DETAILS: THE HUMAN ACHE SEQUENCE OF WAT WAS MODIFIED AT TWO SOURCE 7 POSITIONS, 21 AND 37, TO REPLACE MET AND CYS BY MSE AND SER, SOURCE 8 RESPECTIVELY; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606 KEYWDS HYDROLASE, ACETYLCHOLINESTERASE, SYNAPSE, NEUROTRANSMITTER KEYWDS 2 DEGRADATION, ALTERNATIVE SPLICING, DISEASE MUTATION. EXPDTA X-RAY DIFFRACTION AUTHOR H.DVIR,M.HAREL,S.BON,W.-Q.LIU,M.VIDAL,C.GARBAY,J.L.SUSSMAN, AUTHOR 2 J.MASSOULIE,I.SILMAN REVDAT 3 16-OCT-19 1VZJ 1 REMARK LINK REVDAT 2 24-FEB-09 1VZJ 1 VERSN REVDAT 1 10-JAN-05 1VZJ 0 JRNL AUTH H.DVIR,M.HAREL,S.BON,W.-Q.LIU,M.VIDAL,C.GARBAY,J.L.SUSSMAN, JRNL AUTH 2 J.MASSOULIE,I.SILMAN JRNL TITL THE SYNAPTIC ACETYLCHOLINESTERASE TETRAMER ASSEMBLES AROUND JRNL TITL 2 A POLYPROLINE-II HELIX JRNL REF EMBO J. V. 23 4394 2004 JRNL REFN ISSN 0261-4189 JRNL PMID 15526038 JRNL DOI 10.1038/SJ.EMBOJ.7600425 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MLF REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.9 REMARK 3 NUMBER OF REFLECTIONS : 12889 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 662 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.43 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 59.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 800 REMARK 3 BIN R VALUE (WORKING SET) : 0.5169 REMARK 3 BIN FREE R VALUE : 0.4251 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 36 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2503 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 39 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 55.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.07 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.62700 REMARK 3 B22 (A**2) : 6.27200 REMARK 3 B33 (A**2) : -2.64400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.75700 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.45 REMARK 3 ESD FROM SIGMAA (A) : 0.61 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.42 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.54 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.202 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.73 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.886 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 38.99 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1VZJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-MAY-04. REMARK 100 THE DEPOSITION ID IS D_1290014881. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.60 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96672,0.97927,0.97895,1.5415 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12935 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 29.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.4 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 58.5 REMARK 200 DATA REDUNDANCY IN SHELL : 1.75 REMARK 200 R MERGE FOR SHELL (I) : 0.34900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.470 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE/RESOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% ISOPROPANOL, 10% PEG, 4K 0.05 M REMARK 280 TRISODIUM CITRATE, PH 5.6, PH 5.60 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.39500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: HOMOTETRAMER COMPOSED OF DISULFIDE-LINKED REMARK 300 HOMODIMERS.INTERACTS WITH PRIMA1 TO ANCHOR IT TO REMARK 300 THE BASAL LAMINAOF CELLS AND ORGANIZE INTO REMARK 300 TETRAMERS REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYTIC ACTIVITY: ACETYLCHOLINE + H(2)O = CHOLINE + ACETATE. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 THR A 2 REMARK 465 ASP A 29 REMARK 465 HIS A 30 REMARK 465 TYR A 31 REMARK 465 SER A 32 REMARK 465 LYS A 33 REMARK 465 GLN A 34 REMARK 465 ASP A 35 REMARK 465 ARG A 36 REMARK 465 CYS A 37 REMARK 465 SER A 38 REMARK 465 ASP A 39 REMARK 465 LEU A 40 REMARK 465 SER B 32 REMARK 465 LYS B 33 REMARK 465 GLN B 34 REMARK 465 ASP B 35 REMARK 465 ARG B 36 REMARK 465 CYS B 37 REMARK 465 SER B 38 REMARK 465 ASP B 39 REMARK 465 LEU B 40 REMARK 465 LYS C 33 REMARK 465 GLN C 34 REMARK 465 ASP C 35 REMARK 465 ARG C 36 REMARK 465 CYS C 37 REMARK 465 SER C 38 REMARK 465 ASP C 39 REMARK 465 LEU C 40 REMARK 465 LYS D 33 REMARK 465 GLN D 34 REMARK 465 ASP D 35 REMARK 465 ARG D 36 REMARK 465 CYS D 37 REMARK 465 SER D 38 REMARK 465 ASP D 39 REMARK 465 LEU D 40 REMARK 465 ASP E 1 REMARK 465 ASP E 29 REMARK 465 HIS E 30 REMARK 465 TYR E 31 REMARK 465 SER E 32 REMARK 465 LYS E 33 REMARK 465 GLN E 34 REMARK 465 ASP E 35 REMARK 465 ARG E 36 REMARK 465 CYS E 37 REMARK 465 SER E 38 REMARK 465 ASP E 39 REMARK 465 LEU E 40 REMARK 465 ASP F 35 REMARK 465 ARG F 36 REMARK 465 CYS F 37 REMARK 465 SER F 38 REMARK 465 ASP F 39 REMARK 465 LEU F 40 REMARK 465 ASP G 35 REMARK 465 ARG G 36 REMARK 465 CYS G 37 REMARK 465 SER G 38 REMARK 465 ASP G 39 REMARK 465 LEU G 40 REMARK 465 LYS H 33 REMARK 465 GLN H 34 REMARK 465 ASP H 35 REMARK 465 ARG H 36 REMARK 465 CYS H 37 REMARK 465 SER H 38 REMARK 465 ASP H 39 REMARK 465 LEU H 40 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG C 8 CD NE CZ NH1 NH2 REMARK 470 SER C 32 OG REMARK 470 GLN F 27 CD OE1 NE2 REMARK 470 GLN F 34 CG CD OE1 NE2 REMARK 470 GLU G 5 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 27 -5.22 -59.31 REMARK 500 SER G 32 33.34 -83.96 REMARK 500 TYR H 31 53.42 -95.52 REMARK 500 TYR H 31 54.77 -93.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1B41 RELATED DB: PDB REMARK 900 HUMAN ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN-II, REMARK 900 GLYCOSYLATED PROTEIN REMARK 900 RELATED ID: 1F8U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MUTANT E202Q OF HUMANACETYLCHOLINESTERASE REMARK 900 COMPLEXED WITH GREEN MAMBA VENOMPEPTIDE FASCICULIN-II REMARK 900 RELATED ID: 2CLJ RELATED DB: PDB REMARK 900 HOMOLOGY-BUILT MODEL OF HUMAN ACETYLCHOLINESTERASE REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUE 37 IN CHAINS A-H HAS BEEN MUTATED TO A CYS FROM A SER REMARK 999 BUT WAS NOT VISIBLE IN THE ELECTRON DENSITY MAP FOR THIS ENTRY DBREF 1VZJ A 1 40 UNP P22303 ACES_HUMAN 575 614 DBREF 1VZJ B 1 40 UNP P22303 ACES_HUMAN 575 614 DBREF 1VZJ C 1 40 UNP P22303 ACES_HUMAN 575 614 DBREF 1VZJ D 1 40 UNP P22303 ACES_HUMAN 575 614 DBREF 1VZJ E 1 40 UNP P22303 ACES_HUMAN 575 614 DBREF 1VZJ F 1 40 UNP P22303 ACES_HUMAN 575 614 DBREF 1VZJ G 1 40 UNP P22303 ACES_HUMAN 575 614 DBREF 1VZJ H 1 40 UNP P22303 ACES_HUMAN 575 614 DBREF 1VZJ I 1 15 UNP Q9Y215 COLQ_HUMAN 53 67 DBREF 1VZJ J 1 15 UNP Q9Y215 COLQ_HUMAN 53 67 SEQRES 1 A 40 ASP THR LEU ASP GLU ALA GLU ARG GLN TRP LYS ALA GLU SEQRES 2 A 40 PHE HIS ARG TRP SER SER TYR MSE VAL HIS TRP LYS ASN SEQRES 3 A 40 GLN PHE ASP HIS TYR SER LYS GLN ASP ARG CYS SER ASP SEQRES 4 A 40 LEU SEQRES 1 B 40 ASP THR LEU ASP GLU ALA GLU ARG GLN TRP LYS ALA GLU SEQRES 2 B 40 PHE HIS ARG TRP SER SER TYR MSE VAL HIS TRP LYS ASN SEQRES 3 B 40 GLN PHE ASP HIS TYR SER LYS GLN ASP ARG CYS SER ASP SEQRES 4 B 40 LEU SEQRES 1 C 40 ASP THR LEU ASP GLU ALA GLU ARG GLN TRP LYS ALA GLU SEQRES 2 C 40 PHE HIS ARG TRP SER SER TYR MSE VAL HIS TRP LYS ASN SEQRES 3 C 40 GLN PHE ASP HIS TYR SER LYS GLN ASP ARG CYS SER ASP SEQRES 4 C 40 LEU SEQRES 1 D 40 ASP THR LEU ASP GLU ALA GLU ARG GLN TRP LYS ALA GLU SEQRES 2 D 40 PHE HIS ARG TRP SER SER TYR MSE VAL HIS TRP LYS ASN SEQRES 3 D 40 GLN PHE ASP HIS TYR SER LYS GLN ASP ARG CYS SER ASP SEQRES 4 D 40 LEU SEQRES 1 E 40 ASP THR LEU ASP GLU ALA GLU ARG GLN TRP LYS ALA GLU SEQRES 2 E 40 PHE HIS ARG TRP SER SER TYR MSE VAL HIS TRP LYS ASN SEQRES 3 E 40 GLN PHE ASP HIS TYR SER LYS GLN ASP ARG CYS SER ASP SEQRES 4 E 40 LEU SEQRES 1 F 40 ASP THR LEU ASP GLU ALA GLU ARG GLN TRP LYS ALA GLU SEQRES 2 F 40 PHE HIS ARG TRP SER SER TYR MSE VAL HIS TRP LYS ASN SEQRES 3 F 40 GLN PHE ASP HIS TYR SER LYS GLN ASP ARG CYS SER ASP SEQRES 4 F 40 LEU SEQRES 1 G 40 ASP THR LEU ASP GLU ALA GLU ARG GLN TRP LYS ALA GLU SEQRES 2 G 40 PHE HIS ARG TRP SER SER TYR MSE VAL HIS TRP LYS ASN SEQRES 3 G 40 GLN PHE ASP HIS TYR SER LYS GLN ASP ARG CYS SER ASP SEQRES 4 G 40 LEU SEQRES 1 H 40 ASP THR LEU ASP GLU ALA GLU ARG GLN TRP LYS ALA GLU SEQRES 2 H 40 PHE HIS ARG TRP SER SER TYR MSE VAL HIS TRP LYS ASN SEQRES 3 H 40 GLN PHE ASP HIS TYR SER LYS GLN ASP ARG CYS SER ASP SEQRES 4 H 40 LEU SEQRES 1 I 15 LEU LEU THR PRO PRO PRO PRO PRO LEU PHE PRO PRO PRO SEQRES 2 I 15 PHE PHE SEQRES 1 J 15 LEU LEU THR PRO PRO PRO PRO PRO LEU PHE PRO PRO PRO SEQRES 2 J 15 PHE PHE MODRES 1VZJ MSE A 21 MET SELENOMETHIONINE MODRES 1VZJ MSE B 21 MET SELENOMETHIONINE MODRES 1VZJ MSE C 21 MET SELENOMETHIONINE MODRES 1VZJ MSE D 21 MET SELENOMETHIONINE MODRES 1VZJ MSE E 21 MET SELENOMETHIONINE MODRES 1VZJ MSE F 21 MET SELENOMETHIONINE MODRES 1VZJ MSE G 21 MET SELENOMETHIONINE MODRES 1VZJ MSE H 21 MET SELENOMETHIONINE HET MSE A 21 8 HET MSE B 21 8 HET MSE C 21 8 HET MSE D 21 8 HET MSE E 21 8 HET MSE F 21 8 HET MSE G 21 8 HET MSE H 21 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 8(C5 H11 N O2 SE) FORMUL 11 HOH *39(H2 O) HELIX 1 1 GLU A 5 PHE A 28 1 24 HELIX 2 2 ASP B 1 GLU B 13 1 13 HELIX 3 3 GLU B 13 TYR B 31 1 19 HELIX 4 4 ASP C 1 SER C 32 1 32 HELIX 5 5 ASP D 1 SER D 32 1 32 HELIX 6 6 GLU E 7 PHE E 28 1 22 HELIX 7 7 ASP F 1 GLU F 13 1 13 HELIX 8 8 GLU F 13 GLN F 34 1 22 HELIX 9 9 ASP G 1 HIS G 30 1 30 HELIX 10 10 ASP H 1 TYR H 31 1 31 LINK C TYR A 20 N MSE A 21 1555 1555 1.32 LINK C MSE A 21 N VAL A 22 1555 1555 1.33 LINK C TYR B 20 N MSE B 21 1555 1555 1.33 LINK C MSE B 21 N VAL B 22 1555 1555 1.33 LINK C TYR C 20 N MSE C 21 1555 1555 1.32 LINK C MSE C 21 N VAL C 22 1555 1555 1.33 LINK C TYR D 20 N MSE D 21 1555 1555 1.33 LINK C MSE D 21 N VAL D 22 1555 1555 1.33 LINK C TYR E 20 N MSE E 21 1555 1555 1.32 LINK C MSE E 21 N VAL E 22 1555 1555 1.33 LINK C TYR F 20 N MSE F 21 1555 1555 1.33 LINK C MSE F 21 N VAL F 22 1555 1555 1.33 LINK C TYR G 20 N MSE G 21 1555 1555 1.32 LINK C MSE G 21 N VAL G 22 1555 1555 1.34 LINK C TYR H 20 N MSE H 21 1555 1555 1.32 LINK C MSE H 21 N VAL H 22 1555 1555 1.33 CRYST1 53.730 58.790 58.800 90.00 111.38 90.00 P 1 21 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018611 0.000000 0.007286 0.00000 SCALE2 0.000000 0.017010 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018264 0.00000 MTRIX1 1 -0.988733 0.015964 0.148832 56.38270 1 MTRIX2 1 0.020030 0.999465 0.025859 22.76779 1 MTRIX3 1 -0.148340 0.028549 -0.988524 76.72089 1